Commercialization And Logistics
-
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
5/29/2025
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
-
Bioprocessing Solutions For Cell Culture
6/16/2025
Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.
-
Bioprocessing Equipment And Automation Product Portfolio Overview
5/19/2025
Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.
-
TruBio Software: Performing A Single Pump Calibration
5/19/2025
Confidently manage your bioprocessing systems with precision and ease by learning how to calibrate a single pump using innovative software, which ensures accurate fluid delivery.
-
Ensure Consistency Across Batches With A Powerful Tool
5/19/2025
Learn how to streamline bioprocess control with an innovative software's Unit Save and Load feature. Save configurations, reduce setup time, and ensure consistency across batches with this powerful tool.
-
Safety And Efficiency Of Source Material Collection
8/18/2023
Expert CTO's detail how automation improves safety and efficiency when collecting source material.
-
Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology
5/6/2024
During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.
-
Ensuring Quality, Driving Customer Confidence
7/15/2025
How does quality assurance help drive scientific progress? A 30-year veteran shares her story of supporting customer needs and the development of groundbreaking new therapeutics.
-
Market Demand For AAV Vectors
11/13/2023
Here, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO detail the key factors driving the adeno associated virus manufacturing market.